Identification of a missense mutation of COL3A1 in a Chinese family with atypical Ehlers-Danlos syndrome using targeted next-generation sequencing

Zhang,Wenwen; Han,Qian; Zhou,Min; Ran,Feng; Qiao,Tong; Yi,Long; Liu,Changjian; Liu,Zhao

doi:10.3892/mmr.2016.6082

Identification of a missense mutation of COL3A1 in a Chinese family with atypical Ehlers-Danlos syndrome using targeted next-generation sequencing

Authors:
- Wenwen Zhang
- Qian Han
- Min Zhou
- Feng Ran
- Tong Qiao
- Long Yi
- Changjian Liu
- Zhao Liu
View Affiliations

Affiliations: Department of Vascular Surgery, Nanjing Drum Tower Hospital, Nanjing University Medical School, Nanjing, Jiangsu 210008, P.R. China, Center for Translational Medicine, Nanjing University Medical School, Nanjing, Jiangsu 210093, P.R. China
Published online on: December 29, 2016 https://doi.org/10.3892/mmr.2016.6082
Pages: 936-940
Copyright: © Zhang et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Aortopathy represents an important cause of mortality in industrialized countries, with a number of genes identified as predispose factors. It can be difficult to identify the genetic lesions underlying this disorder, particularly when the phenotype is atypical. The present study performed targeted next‑generation sequencing of 428 genes associated with cardiovascular diseases in a family with aortopathy, the proband of which presented with abdominal aortic aneurysm rupture only, with tissue fragility noted in surgery. After targeted capture, sequencing and bioinformatics analysis, a missense mutation, p.A1259T, was identified in the collagen type III α1 (COL3A1) gene and co‑segregated with the disease in the family. Crystal structure modeling revealed abnormal hydrogen bonds generated by the mutation, which likely affected the spatial structure of the procollagen C‑propeptide. Mutations in the procollagen C‑propeptide are rare and genotype‑phenotype correlation may explain the atypical manifestations of affected individuals. The results of the present study suggested that targeted gene capture combined with next‑generation sequencing can serve as a useful technique in the genetic diagnosis of aortopathy, particularly in the content of an atypical phenotype.

View Figures

View References

1	Elefteriades JA and Pomianowski P: Practical genetics of thoracic aortic aneurysm. Prog Cardiovasc Dis. 56:57–67. 2013. View Article : Google Scholar : PubMed/NCBI
2	Jondeau G and Boileau C: Familial thoracic aortic aneurysms. Curr Opin Cardiol. 29:492–498. 2014. View Article : Google Scholar : PubMed/NCBI
3	Erbel R, Aboyans V, Boileau C, Bossone E, Bartolomeo RD, Eggebrecht H, Evangelista A, Falk V, Frank H, Gaemperli O, et al: 2014 ESC guidelines on the diagnosis and treatment of aortic diseases: Document covering acute and chronic aortic diseases of the thoracic and abdominal aorta of the adult. The task force for the diagnosis and treatment of aortic diseases of the European society of cardiology (ESC). Eur Heart J. 35:2873–2926. 2014. View Article : Google Scholar : PubMed/NCBI
4	Pyeritz RE: Heritable thoracic aortic disorders. Curr Opin Cardiol. 29:97–102. 2014. View Article : Google Scholar : PubMed/NCBI
5	Milewicz DM, Chen H, Park ES, Petty EM, Zaghi H, Shashidhar G, Willing M and Patel V: Reduced penetrance and variable expressivity of familial thoracic aortic aneurysms/dissections. Am J Cardiol. 82:474–479. 1998. View Article : Google Scholar : PubMed/NCBI
6	Isselbacher EM, Cardenas CL Lino and Lindsay ME: Hereditary influence in thoracic aortic aneurysm and dissection. Circulation. 133:2516–2528. 2016. View Article : Google Scholar : PubMed/NCBI
7	Proost D, Vandeweyer G, Meester JA, Salemink S, Kempers M, Ingram C, Peeters N, Saenen J, Vrints C, Lacro RV, et al: Performant mutation identification using targeted next generation sequencing of 14 thoracic aortic aneurysm genes. Hum Mutat. 36:808–814. 2015. View Article : Google Scholar : PubMed/NCBI
8	Ziganshin BA, Bailey AE, Coons C, Dykas D, Charilaou P, Tanriverdi LH, Liu L, Tranquilli M, Bale AE and Elefteriades JA: Routine genetic testing for thoracic aortic aneurysm and dissection in a clinical setting. Ann Thorac Surg. 100:1604–1611. 2015. View Article : Google Scholar : PubMed/NCBI
9	Wu J, Matthaei H, Maitra A, Dal Molin M, Wood LD, Eshleman JR, Goggins M, Canto MI, Schulick RD, Edil BH, et al: Recurrent GNAS mutations define an unexpected pathway for pancreatic cyst development. Sci Transl Med. 3:92ra662011. View Article : Google Scholar : PubMed/NCBI
10	Cox MP, Peterson DA and Biggs PJ: SolexaQA: At-a-glance quality assessment of illumina second-generation sequencing data. BMC Bioinformatics. 11:4852010. View Article : Google Scholar : PubMed/NCBI
11	Li R, Yu C, Li Y, Lam TW, Yiu SM, Kristiansen K and Wang J: Soap2: An improved ultrafast tool for short read alignment. Bioinformatics. 25:1966–1967. 2009. View Article : Google Scholar : PubMed/NCBI
12	Li H, Handsaker B, Wysoker A, Fennell T, Ruan J, Homer N, Marth G, Abecasis G and Durbin R: 1000 Genome Project Data Processing Subgroup: The sequence alignment/map format and SAMtools. Bioinformatics. 25:2078–2079. 2009. View Article : Google Scholar : PubMed/NCBI
13	Li H and Durbin R: Fast and accurate short read alignment with burrows-wheeler transform. Bioinformatics. 25:1754–1760. 2009. View Article : Google Scholar : PubMed/NCBI
14	McKenna A, Hanna M, Banks E, Sivachenko A, Cibulskis K, Kernytsky A, Garimella K, Altshuler D, Gabriel S, Daly M and DePristo MA: The genome analysis toolkit: A MapReduce framework for analyzing next-generation DNA sequencing data. Genome Res. 20:1297–1303. 2010. View Article : Google Scholar : PubMed/NCBI
15	Hou H, Zhao F, Zhou L, Zhu E, Teng H, Li X, Bao Q, Wu J and Sun Z: Magicviewer: Integrated solution for next-generation sequencing data visualization and genetic variation detection and annotation. Nucleic Acids Res. 38:(Web Server issue). W732–W736. 2010. View Article : Google Scholar : PubMed/NCBI
16	Jin ZB, Mandai M, Yokota T, Higuchi K, Ohmori K, Ohtsuki F, Takakura S, Itabashi T, Wada Y, Akimoto M, et al: Identifying pathogenic genetic background of simplex or multiplex retinitis pigmentosa patients: A large scale mutation screening study. J Med Genet. 45:465–472. 2008. View Article : Google Scholar : PubMed/NCBI
17	Arnold K, Bordoli L, Kopp J and Schwede T: The SWISS-MODEL workspace: A web-based environment for protein structure homology modelling. Bioinformatics. 22:195–201. 2006. View Article : Google Scholar : PubMed/NCBI
18	Beighton P, De Paepe A, Steinmann B, Tsipouras P and Wenstrup RJ: Ehlers-danlos syndromes: Revised nosology, villefranche, 1997. Ehlers-Danlos National Foundation (USA) and Ehlers-Danlos Support Group (UK). Am J Med Genet. 77:31–37. 1998. View Article : Google Scholar : PubMed/NCBI
19	Pepin M, Schwarze U, Superti-Furga A and Byers PH: Clinical and genetic features of Ehlers-Danlos syndrome type iv, the vascular type. N Engl J Med. 342:673–680. 2000. View Article : Google Scholar : PubMed/NCBI
20	Oderich GS, Panneton JM, Bower TC, Lindor NM, Cherry KJ, Noel AA, Kalra M, Sullivan T and Gloviczki P: The spectrum, management and clinical outcome of Ehlers-Danlos syndrome type iv: A 30-year experience. J Vasc Surg. 42:98–106. 2005. View Article : Google Scholar : PubMed/NCBI
21	Jorgensen A, Fagerheim T, Rand-Hendriksen S, Lunde PI, Vorren TO, Pepin MG, Leistritz DF and Byers PH: Vascular Ehlers-Danlos Syndrome in siblings with biallelic COL3A1 sequence variants and marked clinical variability in the extended family. Eur J Hum Genet. 23:796–802. 2015. View Article : Google Scholar : PubMed/NCBI
22	Wendorff H, Pelisek J, Zimmermann A, Mayer K, Seidel H, Weirich G, Hausser I, Siegel C, Zernecke A and Eckstein HH: Early venous manifestation of Ehlers-Danlos syndrome type iv through a novel mutation in COL3A1. Cardiovasc Pathol. 22:488–492. 2013. View Article : Google Scholar : PubMed/NCBI
23	Shalhub S, JH III Black, Cecchi AC, Xu Z, Griswold BF, Safi HJ, Milewicz DM and McDonnell NB: Molecular diagnosis in vascular Ehlers-Danlos syndrome predicts pattern of arterial involvement and outcomes. J Vasc Surg. 60:160–169. 2014. View Article : Google Scholar : PubMed/NCBI
24	Leistritz DF, Pepin MG, Schwarze U and Byers PH: COL3A1 haploinsufficiency results in a variety of Ehlers-Danlos syndrome type IV with delayed onset of complications and longer life expectancy. Genet Med. 13:717–722. 2011. View Article : Google Scholar : PubMed/NCBI
25	Pepin MG, Schwarze U, Rice KM, Liu M, Leistritz D and Byers PH: Survival is affected by mutation type and molecular mechanism in vascular Ehlers-Danlos syndrome (EDS type IV). Genet Med. 16:881–888. 2014. View Article : Google Scholar : PubMed/NCBI
26	Frank M, Albuisson J, Ranque B, Golmard L, Mazzella JM, Bal-Theoleyre L, Fauret AL, Mirault T, Denarié N, Mousseaux E, et al: The type of variants at the COL3A1 gene associates with the phenotype and severity of vascular Ehlers-Danlos syndrome. Eur J Hum Genet. 23:16575–1664. 2015. View Article : Google Scholar
27	Campens L, Callewaert B, Mosquera L Muino, Renard M, Symoens S, De Paepe A, Coucke P and De Backer J: Gene panel sequencing in heritable thoracic aortic disorders and related entities: Results of comprehensive testing in a cohort of 264 patients. Orphan J Rare Dis. 10:92015. View Article : Google Scholar
28	Abayazeed A, Hayman E, Moghadamfalahi M and Cain D: Vascular type Ehlers-Danlos syndrome with fatal spontaneous rupture of a right common iliac artery dissection: Case report and review of literature. J Radiol Case Rep. 8:63–69. 2014.PubMed/NCBI
29	Monroe GR, Harakalova M, van der Crabben SN, Majoor-Krakauer D, Bertoli-Avella AM, Moll FL, Oranen BI, Dooijes D, Vink A, Knoers NV, et al: Familial Ehlers-Danlos syndrome with lethal arterial events caused by a mutation in COL5A1. Am J Med Genet A. 167:1196–1203. 2015. View Article : Google Scholar : PubMed/NCBI